| Cassidy Bell, | |
|
5776 S Crocker St, Littleton, CO 80120-2012 | |
| (303) 347-4994 | |
| Not Available |
| Full Name | Cassidy Bell |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 5776 S Crocker St, Littleton, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649593732 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 1222 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassidy Bell, 5776 S Crocker St, Littleton, CO 80120-2012 Ph: () - | Cassidy Bell, 5776 S Crocker St, Littleton, CO 80120-2012 Ph: (303) 347-4994 |
News Archive
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.
Bristol-Myers Squibb Company today announced that it has signed an agreement to sell its global diabetes business that was part of its collaboration with AstraZeneca. Under terms of the agreement, AstraZeneca will make an upfront payment of $2.7 billion to Bristol-Myers Squibb, with potential regulatory- and sales-based milestone payments of up to $1.4 billion and will make royalty payments based on net sales through 2025.
A survey of more than 422,000 college freshmen found that students who identified as transgender were more likely than their cisgender peers to experience negative consequences from drinking, including memory blackouts, academic problems and conflicts such as arguments or physical fights.
Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen today announced that it has submitted a Supplemental New Drug Application to the U.S. Food and Drug Administration for Somatuline Depot 120mg injection for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
› Verified 6 days ago
Sandra Vizina, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4230 W Belleview Pl, Littleton, CO 80123 Phone: 303-797-3387 | |
Dsanderllc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9635 W Chatfield Ave Unit B, Littleton, CO 80128 Phone: 303-594-8947 | |
Miss Aimee Ann Wakeman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6767 S Broadway, Littleton, CO 80122 Phone: 303-647-5780 | |
Erin N Erickson, OTD, OTR/L, BCPR,CLT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 13456 Kuehster Rd, Littleton, CO 80127 Phone: 303-947-5286 | |
Mrs. Elizabeth Eastman Mogno, MSOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5776 S Crocker St, Littleton, CO 80120 Phone: 303-347-3396 | |
Neve Siegfreid, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 12939 W Berry Dr, Littleton, CO 80127 Phone: 303-319-4740 | |
Peak Pediatric Rehabilitation, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5951 Middlefield Rd Ste 100, Littleton, CO 80123 Phone: 720-328-9920 Fax: 720-328-9920 |